Monday 2/4 Insider Buying Report: BIIB, NRGX Monday, February 4, 10:46 AM ET
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys.
At Biogen (BIIB), a filing with the SEC revealed that on Friday, Director Alexander J. Denner bought 62,800 shares of BIIB, for a cost of $327.59 each, for a total investment of $20.57M. Biogen is trading down about 0.9% on the day Monday. Before this latest buy, Denner made one other buy in the past twelve months, purchasing $12.96M shares at a cost of $269.91 a piece.
And at PIMCO Energy and Tactical Credit Opportunities Fund (NRGX), there was insider buying on Wednesday, by Mark R. Kiesel who bought 280,000 shares at a cost of $20.00 each, for a total investment of $5.6M. This buy marks the first one filed by Kiesel in the past twelve months. PIMCO Energy and Tactical Credit Opportunities Fund is trading up about 0.8% on the day Monday. Kiesel was up about 1.4% on the buy at the high point of today's trading session, with NRGX trading as high as $20.28 in trading on Monday.
For MarketNewsVideo.com, I'm Sayoko Murase.
|